Yasin Keshvargar
Lawyers
Filters
Merit Medical Systems $747.5 million convertible senior notes offering
The 3% convertible senior notes are due 2029
Evolent Health $402.5 million convertible notes offering
The convertible notes are due 2029
Samarco Mineração restructuring
We advised an ad hoc group of financial creditors in one of the first creditor-proposed Brazilian restructurings
Polaris $500 million debut senior notes offering
We advised Polaris on its inaugural investment-grade notes offering
Inventiva $58 million at-the-market offering
The American depositary shares are listed on Nasdaq
Enbridge $9.38 billion Dominion Energy assets acquisition financing
We are advising the arrangers and agent on the transaction
Tetra Tech $575 million convertible notes offering and capped call transactions
The 2.25% convertible senior notes are due 2028
Gracell Biotechnologies PIPE of ordinary shares and warrants
The company’s ADSs are listed on Nasdaq
BMS $35 million investment in Immatics
We advised Immatics on the private placement of ordinary shares
Korro Bio $117 million private placement
The financing is expected to close immediately prior to the completion of Korro Bio’s merger with Frequency Therapeutics